source
- Moonwalk Biosciences raises $70M to advance siRNA obesity therapyMoonwalk Biosciences announced it has secured $70 million in financing to move its obesity program into clinical testing. The funding will support development of a small interfering RNA (siRNA) th…
- ADA panel still reviewing expulsions from June conference, further actions possibleThe American Diabetes Association released top‑line findings on Sept. 1 from an internal panel tasked with reviewing the June 5 expulsion of five members at its New Orleans conference. The full re…